Veprik, Anna https://orcid.org/0000-0002-3904-7151
Denwood, Geoffrey
Liu, Dong
Bany Bakar, Rula https://orcid.org/0000-0002-5643-0195
Morfin, Valentin
McHugh, Kara https://orcid.org/0000-0002-2629-986X
Tebeka, Nchimunya N. https://orcid.org/0000-0003-3916-6107
Vetterli, Laurène
Yonova-Doing, Ekaterina
Gribble, Fiona https://orcid.org/0000-0002-4232-2898
Reimann, Frank https://orcid.org/0000-0001-9399-6377
Hoehn, Kyle L. https://orcid.org/0000-0002-0214-3238
Hemsley, Piers A. https://orcid.org/0000-0003-2950-0634
Ahnfelt-Rønne, Jonas
Rorsman, Patrik https://orcid.org/0000-0001-7578-0767
Zhang, Quan https://orcid.org/0000-0002-3626-4855
de Wet, Heidi https://orcid.org/0000-0002-9871-6909
Cantley, James https://orcid.org/0000-0003-2509-1271
Article History
Received: 3 September 2020
Accepted: 8 February 2022
First Online: 18 March 2022
Competing interests
: The authors declare the following competing interests: K.H. is a co-founder of Continuum Biosciences, a company developing drugs for the treatment of metabolic diseases; K.H. is an Editorial Board Member for Communications Biology but was not involved in the editorial review of, nor the decision to publish this article. All other authors declare that there is no duality of interest associated with their contribution to this paper.